Cygnus Technologies

Antibody Affinity Extraction Outperforms Native Digestion as a Sample Preparation Method for LC-MS Detection of Host Cell Proteins in Drug Substances

May 20, 2024

Predicting Retroviral Particle Clearance with MockV® Retrovirus-like Particles

February 17, 2023

Biopharma Insights - Thought Leadership from Marketers | Paid Program

AAE-MS™ as an Orthogonal Method in Host Cell Protein Analytics

May 17, 2022

Biopharma Insights - Thought Leadership from Marketers | Paid Program

HCP ELISA and HCP Antibody Coverage Analysis Methods

April 05, 2021

Biopharma Insights - Thought Leadership from Marketers | Paid Program

Predicting Viral Clearance at Your Benchtop

July 27, 2020

Biopharma Insights - Thought Leadership from Marketers | Paid Program

Viral contamination is an inherent risk during the manufacture of therapeutic products such as antibodies, vaccines, viral vectors, and plasma derivates.